These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7571377)

  • 21. Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies.
    Tozzini F; Matteucci D; Bandecchi P; Baldinotti F; Poli A; Pistello M; Siebelink KH; Ceccherini-Nelli L; Bendinelli M
    J Virol Methods; 1992 Jun; 37(3):241-52. PubMed ID: 1321834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of feline immunodeficiency virus p24 antigen and p24-specific antibodies by monoclonal antibody-based assays.
    Lombardi S; Poli A; Massi C; Abramo F; Zaccaro L; Bazzichi A; Malvaldi G; Bendinelli M; Garzelli C
    J Virol Methods; 1994 Mar; 46(3):287-301. PubMed ID: 7516344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
    Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous red cell agglutination test for antibodies to feline immunodeficiency virus.
    Wilson KM; Robinson WF; Mitchelhill KI; Bundesen PG; Kemp BE
    Vet Immunol Immunopathol; 1994 Sep; 42(3-4):253-63. PubMed ID: 7810059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The diagnostic specificity and sensitivity and the importance of disease prevalence].
    Lutz H; Winkler GG
    Schweiz Arch Tierheilkd; 1995; 137(6):237-42. PubMed ID: 7481713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral immune response to feline immunodeficiency virus in cats with experimentally induced and naturally acquired infections.
    Egberink HF; Keldermans CE; Koolen MJ; Horzinek MC
    Am J Vet Res; 1992 Jul; 53(7):1133-8. PubMed ID: 1323226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
    Dean GA; LaVoy A; Burkhard MJ
    Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of feline immunodeficiency virus (FIV) proviral DNA in peripheral blood mononuclear cells of cats infected with Japanese strains of FIV.
    Inoshima Y; Tomonaga K; Ikeda Y; Miyazawa T; Mikami T
    J Vet Med Sci; 1995 Jun; 57(3):487-92. PubMed ID: 7548402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor alpha levels in cats experimentally infected with feline immunodeficiency virus: effects of immunization and feline leukemia virus infection.
    Lehmann R; Joller H; Haagmans BL; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):61-9. PubMed ID: 1337403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of commercially available assays of neopterin and beta 2-microglobulin for the assessment of disease progression in FIV-infected cats.
    Beatty JA; Willett B; Dalgleish A; Jarrett O
    Vet Immunol Immunopathol; 1997 May; 56(1-2):185-9. PubMed ID: 9220591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison and interpretation of diagnostic tests for feline immunodeficiency virus infection.
    Barr MC; Pough MB; Jacobson RH; Scott FW
    J Am Vet Med Assoc; 1991 Nov; 199(10):1377-81. PubMed ID: 1666086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
    Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
    Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
    Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New challenges for the diagnosis of feline immunodeficiency virus infection.
    Crawford PC; Levy JK
    Vet Clin North Am Small Anim Pract; 2007 Mar; 37(2):335-50, vii. PubMed ID: 17336678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duration of antibody response following vaccination against feline immunodeficiency virus.
    Westman ME; Malik R; Hall E; Harris M; Hosie MJ; Norris JM
    J Feline Med Surg; 2017 Oct; 19(10):1055-1064. PubMed ID: 27770018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Logical to vaccinate rather than risk infection.
    Valli L
    Can Vet J; 2005 Feb; 46(2):108; author reply 108, 110. PubMed ID: 15825512
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of anti-gag antibodies of feline immunodeficiency virus in cat sera by enzyme-linked immunosorbent assay.
    Furuya T; Hasegawa A; Miyazawa T; Miki K; Mikami T
    Arch Virol; 1992; 124(3-4):355-61. PubMed ID: 1318710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative measurement of antibody inhibiting reverse transcriptase activity in cats naturally infected with feline immunodeficiency virus.
    Saito T; Suzuki K; Imai M; Inaba Y
    J Vet Med Sci; 1997 Sep; 59(9):841-3. PubMed ID: 9342714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of 4 Point-of-Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus.
    Levy JK; Crawford PC; Tucker SJ
    J Vet Intern Med; 2017 Mar; 31(2):521-526. PubMed ID: 28158913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiology of FeLV and FIV infection in the Federal Republic of Germany].
    Fuchs A; Binzel L; Lonsdorfer M
    Tierarztl Prax; 1994 Jun; 22(3):273-7. PubMed ID: 8048038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.